Structure-activity relationships and molecular modeling of the N-(3-pivaloyloxy-2-benzylpropyl)-N′-[4-(methylsulfonylamino)benzyl] thiourea template for TRPV1 antagonism

Bioorganic and Medicinal Chemistry Letters

Volumn 22, Issue 11, 2012, Pages 3656-3660

  Bhondwe, Rahul S ^a   Kang, Dong Wook ^b   Kim, Myeong Seop ^a   Kim, Ho Shin ^a   Park, Seul Gi ^c   Son, Karam ^c   Choi, Sun ^c   Lang Kuhs, Krystle A ^d   Pavlyukovets, Vladimir A ^d   Pearce, Larry V ^d   Blumberg, Peter M ^d   Lee, Jeewoo ^a  

^a Seoul National University   (South Korea)

^b Catholic University of Daegu   (South Korea)

^c Ewha Womans University   (South Korea)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Capsaicin; Molecular modeling; Resiniferatoxin; TRPV1 antagonist; Vanilloid receptor 1

Indexed keywords

ANALGESIC AGENT; N 3 PIVALOYLOXY 2 BENZYLPROPYL N 4 METHYLSULFONYLAMINO BENZYL THIOUREA; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG ANTAGONISM; MOLECULAR MODEL; PHARMACOPHORE; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING SITES; CHO CELLS; CRICETINAE; CRICETULUS; MOLECULAR DYNAMICS SIMULATION; PROTEIN STRUCTURE, TERTIARY; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; THIOUREA; TRPV CATION CHANNELS;

EID: 84861186828     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2012.04.034     Document Type: Article

References (20)

1. A. Szallasi, and P.M. Blumberg Pharmacol. Rev. 51 1999 159
2. M. Tominaga, M.J. Caterina, A.B. Malmberg, T.A. Rosen, H. Gilbert, K. Skinner, B.E. Raumann, A.I. Basbaum, and D. Julius Neuron 21 1998 531
3. M.J. Caterina, M.A. Schumacher, M. Tominaga, T.A. Rosen, J.D. Levine, and D. Julius Nature 389 1997 816
4. P.M. Zygmunt, J. Petersson, D.A. Andersson, H-H. Chuang, M. Sorgard, V. Di Marzo, D. Julius, and E.D. Hogestatt Nature 400 1999 452
5. S.W. Hwang, H. Cho, J. Kwak, S.Y. Lee, C.J. Kang, J. Jung, S. Cho, K.H. Min, Y.G. Suh, D. Kim, and U. Oh Proc. Natl. Acad. Sci. U.S.A. 97 2000 6155
6. C.S.J. Walpole, and R. Wrigglesworth Capsaicin in the Study of Pain 1993 Academic Press 63
7. G. Appendino, and A. Szallasi Life Sci. 60 1997 681
8. A. Szallasi, F. Cruz, and P. Geppetti Trends Mol. Med. 12 2006 545
9. E.A. Voight, and M.E. Kort Expert Opin. Ther. Pat. 20 2010 1
10. J. Lazar, L. Gharat, N. Khairathkar-Joshi, P.M. Blumberg, and A. Szallasi Expert Opin. Drug Discov. 4 2009 159
11. M.J. Gunthorpe, and B.A. Chizh Drug Discovery Today 14 2009 56
12. G.Y. Wong, and N.R. Gavva Brain Res. Rev. 60 2009 267
13. P.R. Kym, M.E. Kort, and C.W. Hutchins Biochem. Pharmacol. 78 2009 211
14. J. Lee, J. Lee, M. Kang, M.-Y. Shin, J.-M. Kim, S.-U. Kang, J.-O. Lim, H.-K. Choi, Y.-G. Suh, H.-G. Park, U. Oh, H.-D. Kim, Y.-H. Park, H.-J. Ha, Y.-H. Kim, A. Toth, Y. Wang, R. Tran, L.V. Pearce, D.J. Lundberg, and P.M. Blumberg J. Med. Chem. 46 2003 3116
15. J. Lee, S.Y. Kim, Ji Lee, M. Kang, M-J. Kil, H-K. Choi, M-K. Jin, Y. Wang, A. Toth, L.V. Pearce, D.J. Lundberg, R. Tran, and P.M. Blumberg Bioorg. Med. Chem. 12 2004 3411
16. H. Ryu, M.-K. Jin, S.-U. Kang, S.Y. Kim, D.W. Kang, J. Lee, L.V. Pearce, V.A. Pavlyukovets, M.A. Morgan, R. Tran, A. Toth, D.J. Lundberg, and P.M. Blumberg J. Med. Chem. 51 2008 57
17. J. Lee, J. Lee, J. Kim, S.Y. Kim, M.W. Chun, H. Cho, S.W. Hwang, U. Oh, Y.H. Park, V.E. Marquez, M. Beheshti, T. Szabo, and P.M. Blumberg Bioorg. Med. Chem. 9 2001 19
18. T. Isoda, K. Hayashi, S. Tamai, T. Kumagai, and Y. Nagao Chem. Pharm. Bull. 54 2006 1616
19. K.H. Min, Y-G. Suh, M-K. Park, H-G. Park, Y-H. Park, H-D. Kim, U. Oh, P.M. Blumberg, and J. Lee [published erratum appears in Mol. Pharmacol. 2003, 63, 958] Mol. Pharm. 62 2002 947
20. J.H. Lee, Y. Lee, H. Ryu, D.W. Kang, J. Lee, J. Lazar, L.V. Pearce, V.A. Pavlyukovets, P.M. Blumberg, and S. Choi J. Comput. Aided Mol. Des. 25 2011 317